Lilly launched project ‘Uday’ in 2012 (in partnership with PHFI, PSI and Project HOPE), an intensive five-year program aiming to fight the rising burden of non-communicable diseases in India, with an initial focus on improving outcomes for people with diabetes and high blood pressure. Based on this unique research, report and advocate framework, this program aims to demonstrate a cost-effective scalable comprehensive model for prevention and management of diabetes and high blood pressure . Through this approach, the program focuses on sharing results with key stakeholders, including government and the global health community to encourage adoption of the best solutions.